Location: West Hollywood, CA
CIK: 0001704132 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value: $153M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | 4,397,881 | $81.45M | 53.2% | $27.29 | -33.0% | COM | N69605108 |
| KURA | Kura Oncology, Inc. | 1,849,947 | $36.15M | 23.6% | $20.39 | -0.6% | COM | 50127T109 |
| SNDX | Syndax Pharmaceuticals, Inc. | 875,000 | $16.84M | 11.0% | $22.62 | -8.7% | COM | 87164F105 |
| — | Lyell Immunopharma, Inc. | 8,325,000 | $11.49M | 7.5% | $16.24 | — | COM | 55083R104 |
| RLAY | Relay Therapeutics Inc. | 1,000,000 | $7.08M | 4.6% | $7.47 | 0.0% | COM | 75943R102 |